March 15, 2010 - Earlier this month, Senator Patrick Leahy (D-Vermont) announced in a press release that the Senate Judiciary Committee has reached a bipartisan agreement and produced an amendment with compromises designed to make the bill ready for a Senate vote.

"This compromise may not be everything that everyone wants," acknowledged Leahy, "but it makes important reforms to the outdated patent system."

On October 16, 2009, the Wall Street Journal reported that twelve Republican senators – apparently feeling left out of the patent reform process – wrote a letter to Senate leaders asking them to reconsider parts of the Patent Reform Act of 2009 that would be deleterious to small businesses, universities and individual inventors.

The article quotes AIPR’s board member Pat Choate as one of the critics of the patent reform bills currently making their way through Congress.

An interesting and disparate coalition of groups has come out in opposition to the proposed Patent Reform Act of 2009, groups that traditionally have nothing to do with each other.

• Pharmaceutical Industry: Pharmaceutical Research and Manufacturers of America (PhRMA) represents the major drug companies.
  
• Biotech: The Biotechnology Industry Organization (BIO) represents research, genetics and other biotech companies.

The U.S. Patent and Trademark Office (“PTO”) complains that it is overwhelmed by the onslaught of patent applications, and seeks to shift to the applicants the burden of finding prior art and distinguishing the claims from it. Two PTO regulations1 provide for applicants to provide a “support document” under certain circumstances.

As you probably recall, Q. Todd Dickinson started as deputy in early 1998 and then served as director of the USPTO until January 2001, during a critical juncture in its history. He dealt with Congress as it passed the American Inventors Protection Act of 1999, the last major legislative amendment to the patent law, and managed the PTO as it was reconstituted a Performance-Based Organization of the government. He also initiated planning for agency’s relocation from Crystal City to the Carlisle Campus in Arlington.

By Alex Poltorak, March 8, 2009

Last Tuesday, March 3, 2009, Senators Patrick Leahy (D-Vermont) and Orrin Hatch (R-Utah), and Representatives John Conyers (D-Michigan) and Lamar Smith (R-Texas) have introduced to the Senate (S. 515) and the House (H.R. 1260) almost identical bills aimed at reforming our patent system. These bills, collectively referred to as the Patent Reform Act of 2009, as expected, are very similar to S. 1145 and H.R. 1908 of the Patent Reform Act of 2007 that failed in the last Congress.

Proposed changes to patent law in the Senate Bill include: